| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105541 Naphthyl compounds, intermediates, compositions, and methods of use |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105514 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic; acidinhibit aldose reductase; treating diabetes mellitus, including, diabetic cataracts, retinopathy, nephropathy, and neuropathy |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/12/2006 | US7105324 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 09/12/2006 | US7105167 Administering variants of insulin-like growth factor I to treat hyperglycemic disorder, congestive heart failure, urogenital disorders, poor nutrition, or a wasting syndrome |
| 09/12/2006 | CA2312545C Solid, thermoformable, controlled-release pharmaceutical compound |
| 09/12/2006 | CA2247179C Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094034A1 Cinnoline compounds and their use as liver x receptor modilators |
| 09/08/2006 | WO2006093354A1 Production intermediate of (s)-2-[3-(n-{[4-(4-fluorophenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenylmethyl]butanoic acid |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093291A1 19-norvitamin d derivative |
| 09/08/2006 | WO2006093290A1 9-substituted-19-norvitamin d derivative |
| 09/08/2006 | WO2006093166A1 Enzyme-treated product comprising rice peptide and composition for improving physiological activity comprising the product |
| 09/08/2006 | WO2006093014A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 09/08/2006 | WO2006093013A1 Serum cholesterol-reducing agent, process for production of the same, and food composition and pharmaceutical composition having serum cholesterol-reducing effect |
| 09/08/2006 | WO2006092507A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 09/08/2006 | WO2006092209A1 Novel targets and compounds useful in the treatment of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds |
| 09/08/2006 | WO2006092204A1 Derivatives of aminobutanoic acid inhibiting cpt |
| 09/08/2006 | WO2006092081A1 Insulin analogs from euphorbia lunulata extracts and the use thereof and the use of interleukin-10 analogs |
| 09/08/2006 | WO2006092025A1 Compounds having lipid lowering properties |
| 09/08/2006 | WO2006077025A3 Morpholines as 5ht2c agonists |
| 09/08/2006 | WO2006077024A3 5-aminoindole derivatives |
| 09/08/2006 | WO2006048665A3 Polymorphs of sarsapogenin |
| 09/08/2006 | WO2006029634A3 Pharmaceutical compositions containing insulin and insulinotropic peptide |
| 09/08/2006 | WO2006007851A3 Capsaicin inhibitors for treating obesity and-related disorders |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599848A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 09/08/2006 | CA2599688A1 Cinnoline compounds and their use as liver x receptor modulators |
| 09/08/2006 | CA2599612A1 Use of phosphate derivatives of electron transfer agents for lowering increased circulating blood levels of a lipid |
| 09/08/2006 | CA2599331A1 Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals preparation comprising the same |
| 09/08/2006 | CA2599165A1 Derivatives of aminobutanoic acid inhibiting cpt |
| 09/08/2006 | CA2586208A1 Human obesity susceptibility gene encoding potassium ion channels and uses thereof |
| 09/07/2006 | US20060199966 Indol-2-amides as glycogen phosphorylase inhibitors |
| 09/07/2006 | US20060199962 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 09/07/2006 | US20060199869 Reducing digestion of lipids to treat or prevent obesity by administering an acyclic amine optionally containing ether groups or a sulfide group, e.g., 2-(Dimethylamino)ethyl stearyl ether, N,N-dimethylhexadecylamine, or 2-(Diisopropylamino)ethyl dodecyl ether |
| 09/07/2006 | US20060199861 Methods of using derivatives of (-)-venlafaxine |
| 09/07/2006 | US20060199860 Salts of (-)-O-desmethylvenlafaxine |
| 09/07/2006 | US20060199854 allows to recycle all solvents and the only by-products are inorganic salts; high overall yield and is suitable for industrial production |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/07/2006 | US20060199793 Sterol absorption inhibitor compounds |
| 09/07/2006 | US20060199761 Insulin resistance improving agent |
| 09/07/2006 | US20060199759 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | US20060198788 Method of evaluating compound efficacious in treating obesity by using slc25a10 |
| 09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
| 09/06/2006 | EP1698697A2 SSD-containing protein, process for producing the same and use thereof |
| 09/06/2006 | EP1698696A1 Target protein of antidiabetic agent and novel antidiabetic agent insuful corresponding thereto |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1698343A1 Foodstuff produced with extract of peanut stem for regulating blood sugar |
| 09/06/2006 | EP1698329A1 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 09/06/2006 | EP1698235A1 Functional component-enriched barley malt rootlets and process for producing the same |
| 09/06/2006 | EP1697401A1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 09/06/2006 | EP1697362A1 Crf receptor antagonists and methods relating thereto |
| 09/06/2006 | EP1697306A1 Selective peroxisome proliferator activated receptor modulators |
| 09/06/2006 | EP1696962A2 Novel glp-1 analogues linked to albumin-like agents |
| 09/06/2006 | EP1696956A2 Anti-cd52 antibody treatment for diabetes |
| 09/06/2006 | EP1696946A1 Use of interferon tau for the treatment of obesity and for promotion of weight loss |
| 09/06/2006 | EP1696937A1 Prebiotic combination products |
| 09/06/2006 | EP1696924A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1696909A1 Benzothiazole derivatives for the treatment of diabetes |
| 09/06/2006 | EP1696902A2 Compositions containing d-tocopherol compound polybasic acid partial esters |
| 09/06/2006 | EP1696897A1 Compositions and methods for treating diabetes |
| 09/06/2006 | EP1696859A2 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 09/06/2006 | EP1539928A4 Cd56 positive human adult pancreatic endocrine progenitor cells |
| 09/06/2006 | EP1458673B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/06/2006 | EP1444328A4 Induction of beta cell differentiation in human cells |
| 09/06/2006 | EP1420771B1 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 09/06/2006 | EP1401464B1 Dietetic preparation with hypocholesterolemic activity |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1023435B1 Novel lactic acid bacteria species |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | CN1829728A 新颖化合物 Novel compounds |
| 09/06/2006 | CN1829715A Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 09/06/2006 | CN1829701A Piperazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829699A Pyridazinyl- piperazines and their use as histamine h3 receptor |
| 09/06/2006 | CN1829698A Pyridazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829691A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829690A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829528A Compositions comprising gastrin compounds and their use in diabetes |